Latest Biology Technology from Bio-Medicine.Org

Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research

Mon, 12 May 2008 09:08:22 MST

NEW YORK, May 13 /- Johnson & Johnson today announced that Professor Marc Feldmann, FMedSci, FAA, FRS and Emeritus Professor Sir Ravinder N. Maini, FRCP, FMedSci, FRS of the Kennedy Institute of Rheumatology, Imperial College London have been named the recipients of the 2008 Dr. Paul Janssen Award for Biomedical Research by an independent selection committee of world-renowned sc...

University Research and Science Parks Create Sustainable Innovation

Mon, 12 May 2008 08:01:40 MST

SAN DIEGO and TUCSON, Ariz., May 12 /PRNewswire-USNewswire/ -- University-affiliated research, science and technology parks have become crucial in creating opportunities for sustainable development and innovation within economies across the globe. Experts in park development will gather in La Jolla on June 16 to share information on the best practices and emerging trends in maximizing the ef...

Federal government taps NC State experts to explain nanotech risks

Mon, 12 May 2008 07:05:33 MST

The arm of the federal government responsible for coordinating nanotechnology research and regulations across the country has called on experts from North Carolina State University to craft a white paper that will lay out how government and industry officials should communicate potential risks associated with nanotechnology to the media and the public. NC State communication expert Dr. David...

Two New Appointments at Meditor Pharmaceuticals Ltd.

Mon, 12 May 2008 04:18:17 MST

REHOVOT, Israel, May 12 /- Meditor Pharmaceuticals Ltd. announced today the appointment of Prof. Arie Schachner to serve as a Senior Medical Advisor to the company. Dr. Schachner has been a member of Meditor's Scientific Advisory Board since 2001 and will now take a more active role in the Clinical Development program. Prof. Schachner was the founder and Head of the Cardiac...

Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences

Mon, 12 May 2008 04:18:04 MST

SAN DIEGO, May 12 /- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced today that it will present at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Monday, May 19, 2008 at 10:00 a.m. CEST (4:00 a.m. EDT/1:00 a.m. PDT) at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, wi...

Controller's Stem Cell Agency Audit Ignores California Agency's Built-in Flaws

Mon, 12 May 2008 03:04:57 MST

SANTA MONICA, Calif., May 12 /PRNewswire-USNewswire/ -- An audit of the state stem cell agency by California's Controller ignores fundamental flaws in Proposition 71 that created the agency, Consumer Watchdog said today. The audit released by State Controller John Chiang found that with a relatively minor exception the California Institute for Regenerative Medicine (CIRM) complies with t...

Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates

Mon, 12 May 2008 02:10:21 MST

MOUNTAIN VIEW, Calif., May 12 /- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) reported today financial results for its fiscal quarter ended March 31, 2008 and provided an update on the Company's progress with its product candidates. The net loss for the 2008 first fiscal quarter, as reported in accordance with accounting principles generally accepted in the United Sta...

MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments

Mon, 12 May 2008 02:10:03 MST

NEW YORK, May 12 /- MGT Capital Investments, Inc. (AMEX: MGT ), a technology holding company focused on the Healthcare Information Technology ("HCIT") sector, today reported financial results for the first quarter ended March 31, 2008, and provided an update on strategic milestones. Tim Paterson-Brown, MGT Chairman and CEO, stated, "We anticipate 2008 will be a sign...

Expansion and Relocation to New, State-Of-The-Art Facilities Marks Milestone in Effort to Roll Out New Tool for Cancer Diagnosis

Mon, 12 May 2008 01:21:36 MST

Company Announces Closing of Insider Round of Financing for $3 Million PITTSBURGH, May 12 /- Continued increasing sales of RedPath Integrated Pathology, Inc.'s PathFinderTG(R) have fueled the company's expansion and relocation into new, state-of-the-art headquarters in Pittsburgh and the growth of the company's work force which now totals 50, up from 20 a year ago. Against this...

Idenix Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference

Mon, 12 May 2008 01:21:24 MST

CAMBRIDGE, Mass., May 12 /- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ) announced today that Idenix management will present a corporate overview at the Rodman & Renshaw 5th Annual Global Healthcare Conference on Tuesday, May 20, 2008 at 12:00 p.m. CEST at Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. The live and archived webcast of the company presentation...

Verenium Appoints John F. Dee to Board of Directors

Mon, 12 May 2008 01:21:07 MST

- Adds significant strategic biotech business experience - CAMBRIDGE, Mass., May 12 /. Verenium Corporation (Nasdaq: VRNM ), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today announced the appointment of John F. Dee to its Board of Directors. The Company also announced that Geoffrey Hazlewood, Ph.D....

MedQuist Reports First Quarter 2008 Results

Mon, 12 May 2008 12:09:00 MST

MOUNT LAUREL, N.J., May 12 /- MedQuist Inc. (Pink Sheets: MEDQ), the largest Medical Transcription Service Organization (MTSO) in the world, on Friday, May 9th, filed its Form 10-Q quarterly report with the U.S. Securities and Exchange Commission for the quarter ended March 31, 2008. Revenue for the first quarter of 2008 was $83.7M compared with $89.1M in the first q...

Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference

Mon, 12 May 2008 12:08:48 MST

- Presentation to be Webcast - MONTVALE, N.J., May 12 /- Synvista Therapeutics, Inc. (Amex: SYI ) announced today that Noah Berkowitz, M.D., Ph.D. President and Chief Executive Officer of Synvista will present at the upcoming Rodman & Renshaw 5th Annual Global Healthcare Conference on Monday, May 19, 2008 at 12:10 p.m. CEST (6:10 a.m. EDT). The ev...

A Scientist Dechipers the Code to Beautiful, Healthy Skin in 'The New Science of Perfect Skin'

Mon, 12 May 2008 12:08:37 MST

FREEPORT, N.Y., May 12 /- "What's the difference between a peptide and an enzyme?" "Can creams really repair my DNA?" Hundreds of women are trying to crack the beauty secret: what ingredients and which products will give me beautiful, healthy skin? Bio-scientist turned skin-care pioneer Daniel Yarosh, Ph.D. takes his skin care expertise -- more than 20 years of researching, ma...

Neurocrine Biosciences to Present at the 2008 Citi Investment Research Global Health Care Conference

Mon, 12 May 2008 11:14:09 MST

Live Audio Webcast Thursday, May 22, 2008 SAN DIEGO, May 12 /- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that Neurocrine Biosciences will present at the Citi Investment Research Global Health Care Conference at the Hilton New York. The live presentation takes place Thursday, May 22, 2008 at 3:00 p.m. Eastern Time (ET) /12:00 p.m. Paci...

Informed Medical Communications Hires New Vice President of Marketing

Mon, 12 May 2008 11:13:58 MST

EDISON, N.J., May 12 /- Informed Medical Communications (IMC), a leading provider of peer-to-peer medical forums for the bio-pharmaceutical industry, today announced the appointment of Scott Stoogenke, as Vice President, Marketing. In this role, Stoogenke will develop and implement marketing strategies for Peer Group, RxDialogue and IMC with the objective to maintain and grow IM...

TorreyPines Therapeutics to Host First Quarter 2008 Results Conference Call and Webcast

Mon, 12 May 2008 11:13:48 MST

LA JOLLA, Calif., May 12 /- TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) today announced that the company will conduct a conference call and audio webcast on Tuesday, May 13, 2008 at 11:00 a.m., Eastern Time (ET), in conjunction with the release of its financial results for the first quarter ended March 31, 2008. TorreyPines anticipates releasing its financial resul...

Neuralstem Responds to New StemCells, Inc. Lawsuit

Mon, 12 May 2008 11:13:35 MST

ROCKVILLE, Md., May 12 /- Stem cell company Neuralstem, Inc. (Amex: CUR ) responded today to the two new patent infringement suits filed against it Friday by StemCells, Inc., saying that it believes them, and the earlier claims by StemCells, Inc. against the company, to be baseless. (Logo: http://www.newscom.com/cgi-bin/prnh/20061221/DCTH007LOGO ) "As we alleged...

Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex

Mon, 12 May 2008 08:56:55 MST

Completion honors Lilly's commitment to the community and its biotech pipeline INDIANAPOLIS, May 12 /- Eli Lilly and Company (NYSE: LLY ) announced today completion of the final phase of its $1 billion effort to further strengthen the company's biotechnology research and development capabilities. At a ceremony at its Indianapolis oper...

MedApps Selected as Dell-NFIB 2008 Business Excellence Award Finalist

Mon, 12 May 2008 08:56:40 MST

SCOTTSDALE, Ariz., May 12 /- MedApps announced today, that it has been selected as one of the nation's 10 most innovative companies as part of Dell's 2008 Global Small Business Excellence Award. ( http://www.dell.com/ceaward ) The MedApps Mobile Wireless Health Monitoring System helps connect people afflicted with chronic disease like Diabetes, Asthma, Congestive Heart Failure...